P/E spoločnosti RepliCel Life Sciences
Aká je hodnota metriky P/E spoločnosti RepliCel Life Sciences?
Hodnota metriky P/E spoločnosti RepliCel Life Sciences, Inc. je N/A
Aká je definícia metriky P/E?
P/E ratio je koeficient daný pomerom ceny akcie a príjmu spoločnosti na akciu za posledných 12 mesiacov.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E spoločností v sektore Health Care sektor na TSXV v porovnaní so spoločnosťou RepliCel Life Sciences
Čomu sa venuje spoločnosť RepliCel Life Sciences?
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that is in Phase 2 clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase 2 clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.
Firmy s metrikou p/e podobnou spoločnosti RepliCel Life Sciences
- Hodnota metriky P/E spoločnosti Catalent je N/A
- Hodnota metriky P/E spoločnosti BP Plc je N/A
- Hodnota metriky P/E spoločnosti GrowGeneration je N/A
- Hodnota metriky P/E spoločnosti PetroFrontier je N/A
- Hodnota metriky P/E spoločnosti StoneMor Inc je N/A
- Hodnota metriky P/E spoločnosti Truecar Inc je N/A
- Hodnota metriky P/E spoločnosti RepliCel Life Sciences je N/A
- Hodnota metriky P/E spoločnosti SPDR MSCI Europe UCITS ETF je N/A
- Hodnota metriky P/E spoločnosti Reaves Utility Income Fund je N/A
- Hodnota metriky P/E spoločnosti AgJunction je N/A
- Hodnota metriky P/E spoločnosti ABIONYX Pharma SA je N/A
- Hodnota metriky P/E spoločnosti Pacific Horizon Investment Trust Plc je N/A
- Hodnota metriky P/E spoločnosti EJF Investments je N/A